We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GSUN:NASDAQGolden Sun Technology Group Limited Analysis

Data as of 2026-06-01 - not real-time

$0.42

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Golden Sun Technology Group Limited (GSUN) is trading at $0.42, well below its 20‑day SMA of $0.46 and the 50‑day SMA of $0.49, indicating short‑term weakness. The 200‑day SMA sits near $1.47, underscoring a long‑term downtrend. The RSI of 43 and a bearish MACD histogram reinforce a momentum shift to the downside. Volume has been decreasing, and the MACD signal is labeled “bearish,” suggesting limited buying pressure. The stock is hovering near the technical support of $0.351 with resistance around $0.617, leaving little upside cushion. Volatility is extreme at roughly 173% over the past 30 days, amplifying price swings.
Fundamentally, the company reports a revenue of $35.5 million but margins are razor‑thin, with a gross margin of just 2.3% and an operating loss of 4.7%. Net profit margin is –14.3% and EBITDA is negative, leading to a trailing EPS of –$2.08 and no forward earnings guidance. Debt outweighs equity (debt‑to‑equity ≈ 58%) and cash balances of $0.78 million are insufficient to cover the $5.1 million debt load. Despite the bleak earnings, the market values the shares at a price‑to‑book of 0.40 and a price‑to‑sales of 0.12, which are deep discounts to book and sales. The education sector in China faces stringent regulatory scrutiny, adding a high regulatory headwind to the business outlook. Combined with low liquidity, a small market cap of $4.3 million, and exposure to Chinese yuan fluctuations, the risk profile remains elevated.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below short‑term moving averages
  • negative earnings and cash flow
  • high regulatory risk in Chinese education sector

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • deep discount to book value
  • potential restructuring of debt
  • uncertain regulatory environment

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • exposure to low‑cost valuation
  • possible asset liquidation
  • persistent sector headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth304.60%
Profit Margin-14.34%
ROE-128.83%
ROA-6.40%
Debt/Equity58.16
P/B Ratio0.4
Op. Cash Flow$-9318172
Free Cash Flow$-6279636

Technical Analysis

TrendBearish
RSI43.2
Support$0.35
Resistance$0.62
MA 20$0.46
MA 50$0.49
MA 200$1.47
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.71
Volatility172.91%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.